Detalhe da pesquisa
1.
Nonclassical CD4+CD49b+ Regulatory T Cells as a Better Alternative to Conventional CD4+CD25+ T Cells To Dampen Arthritis Severity.
J Immunol
; 196(1): 298-309, 2016 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26590312
2.
A new autoinflammatory and autoimmune syndrome associated with NLRP1 mutations: NAIAD (NLRP1-associated autoinflammation with arthritis and dyskeratosis).
Ann Rheum Dis
; 76(7): 1191-1198, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27965258
3.
DX5+ CD4+ T cells modulate CD4+ T-cell response via inhibition of IL-12 production by DCs.
Eur J Immunol
; 43(2): 439-46, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23169063
4.
Nicotinamide phosphoribosyltransferase/visfatin expression by inflammatory monocytes mediates arthritis pathogenesis.
Ann Rheum Dis
; 72(10): 1717-24, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23313810
5.
Intra-articular delivery of full-length antibodies through the use of an in situ forming depot.
J Control Release
; 341: 578-590, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34915070
6.
DX5(+)CD4(+) T cells modulate cytokine production by CD4(+) T cells towards IL-10 via the production of IL-4.
Eur J Immunol
; 40(10): 2731-40, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20812238
7.
DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) Treg.
Eur J Immunol
; 39(7): 1765-73, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19544486
8.
Adoptive transfer of IL-10-secreting CD4+CD49b+ regulatory T cells suppresses ongoing arthritis.
J Autoimmun
; 34(4): 390-9, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19880290
9.
Differential Accumulation and Activation of Monocyte and Dendritic Cell Subsets in Inflamed Synovial Fluid Discriminates Between Juvenile Idiopathic Arthritis and Septic Arthritis.
Front Immunol
; 11: 1716, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32849606
10.
Antitumoral activity and osteogenic potential of mesenchymal stem cells expressing the urokinase-type plasminogen antagonist amino-terminal fragment in a murine model of osteolytic tumor.
Stem Cells
; 26(11): 2981-90, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18757301
11.
Tripartite siRNA micelles as controlled delivery systems for primary dendritic cells.
Drug Dev Ind Pharm
; 35(8): 950-8, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19274590
12.
Arthritis sensory and motor scale: predicting functional deficits from the clinical score in collagen-induced arthritis.
Arthritis Res Ther
; 21(1): 264, 2019 12 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31801618
13.
Polyoxidonium® Activates Cytotoxic Lymphocyte Responses Through Dendritic Cell Maturation: Clinical Effects in Breast Cancer.
Front Immunol
; 10: 2693, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31849934
14.
Injection of Adipose-Derived Stromal Cells in the Knee of Patients with Severe Osteoarthritis has a Systemic Effect and Promotes an Anti-Inflammatory Phenotype of Circulating Immune Cells.
Theranostics
; 8(20): 5519-5528, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30555561
15.
Micro-CT combined with bioluminescence imaging: a dynamic approach to detect early tumor-bone interaction in a tumor osteolysis murine model.
Bone
; 40(4): 1032-40, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17251073
16.
Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells.
Transplantation
; 82(8): 1060-6, 2006 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-17060855
17.
Cellular senescence impact on immune cell fate and function.
Aging Cell
; 15(3): 400-6, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26910559
18.
Systemic LPS Translocation Activates Cross-Presenting Dendritic Cells but Is Dispensable for the Breakdown of CD8+ T Cell Peripheral Tolerance in Irradiated Mice.
PLoS One
; 10(6): e0130041, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26075613
19.
Versatile polyion complex micelles for peptide and siRNA vectorization to engineer tolerogenic dendritic cells.
Eur J Pharm Biopharm
; 92: 216-27, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25796349
20.
Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis.
Arthritis Res Ther
; 16(3): R115, 2014 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24886976